Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. Their investigational allogeneic T-cell immunotherapies harness the power of regulatory T cells to provide better outcomes with fewer risks for patients.

Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. Their investigational allogeneic T-cell immunotherapies harness the power of regulatory T cells to provide better outcomes with fewer risks for patients.